title: Cholesterol lowering. Should it continue to be the last thing we do?
authors.forename: D
authors.initials: D
authors.lastname: Waters
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D004334:Drug Administration Schedule; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D017035:Pravastatin / Q000008:administration & dosage* / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D017035:Pravastatin